Vincent Angotti Buys 213,310 Shares of Talphera (NASDAQ:TLPH) Stock

Talphera, Inc. (NASDAQ:TLPH) CEO Vincent Angotti acquired 213,310 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The shares were purchased at an average price of $0.59 per share, with a total value of $125,852.90. Following the completion of the transaction, the chief executive officer owned 800,705 shares of the company’s stock, valued at $472,415.95. The trade was a 36.31% increase in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Talphera Price Performance

TLPH stock traded up $0.07 during trading on Wednesday, reaching $0.80. 427,472 shares of the stock were exchanged, compared to its average volume of 209,643. The business has a 50 day moving average price of $0.88 and a 200-day moving average price of $1.05. Talphera, Inc. has a 1 year low of $0.38 and a 1 year high of $1.57.

Talphera (NASDAQ:TLPH) last posted its quarterly earnings results on Monday, March 23rd. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.02. Analysts predict that Talphera, Inc. will post -0.64 earnings per share for the current year.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Talphera in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $6.00.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the business. AIGH Capital Management LLC purchased a new position in Talphera in the third quarter valued at $3,979,000. Rosalind Advisors Inc. lifted its position in Talphera by 118.9% in the third quarter. Rosalind Advisors Inc. now owns 4,385,757 shares of the company’s stock valued at $3,917,000 after acquiring an additional 2,381,818 shares during the last quarter. Cantor Fitzgerald L. P. acquired a new position in Talphera in the fourth quarter valued at $658,000. Geode Capital Management LLC boosted its stake in Talphera by 107.0% in the fourth quarter. Geode Capital Management LLC now owns 342,987 shares of the company’s stock valued at $391,000 after acquiring an additional 177,294 shares in the last quarter. Finally, Renaissance Technologies LLC grew its holdings in shares of Talphera by 412.6% during the fourth quarter. Renaissance Technologies LLC now owns 257,380 shares of the company’s stock worth $293,000 after purchasing an additional 207,166 shares during the last quarter. Hedge funds and other institutional investors own 37.67% of the company’s stock.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.